Summary. The intrauterine injection of 7-oxa-13-prostynoic acid, 18,18,20\x=req-\ trimethyl PGE-2, and meclofenamic acid in mice at the expected times of implantation significantly reduced the number of implantation sites. Indomethacin was ineffective possibly because it was exposed to high pH during the preparation of the solutions for injection. It is suggested that these prostaglandin antagonists exert their antifertility action at multiple sites involving both the embryo and mother.
Introduction
Biggers, Leonov, Baskar & Fried (1978) have suggested that a medicated intrauterine device (IUD) releasing a prostaglandin antagonist may be a particularly effective contraceptive. The proposal was stimulated by the observation that 7-oxa-13-prostynoic acid and meclofenamic acid prevent hatching of mouse blastocysts in vitro. Baskar, Torchiana, Biggers, Corey, Andersen & Subramanian (1981) have found that 18,18,20-trimethyl prostaglandin E-2 inhibits hatching with an activity that may be intermediate between 7-oxa-13-prostynoic acid and meclofenamic acid. These observations raise the possibility that prostaglandin plays essential roles in preimplantation development. The proposal of a medicated IUD releasing a prostaglandin antagonist was also supported by evidence that systemically administered prostaglandin antagonists may (1) reduce fertility in the rabbit and mouse, and possibly the rat, and (2) ameliorate symptoms of dysmenorrhoea and the undesirable effects of the copper-7-IUD in women. Thus, the local release of antagonists of prostaglandin function from an IUD could theoretically interfere with implantation and simultaneously diminish undesirable side effects of the IUD itself.
Confidence in the proposal of a medicated IUD releasing an inhibitor of prostaglandin function would be enhanced by the demonstration that low doses of these compounds inhibit fertility following instillation into the uterus at the expected time of implantation and this possibility has been investigated in this paper.
Materials and Methods Animals and anaesthesia
Virgin 6-8-week-old CF-1 random-bred female mice from Charles River Breeding Laboratory, Wilmington, Massachusetts, were used. They were induced to ovulate syn-chronously by the injection of 2-5 i.u. PMSG (Sigma, St Louis, Missouri) followed 48 h later by [2] [3] [4] [5] (Sigma) (Cochran & Cox, 1957) was adopted throughout. The pair of treatments applied to each female was allotted at random using tables of random numbers, and the treatments within each pair were allotted to right and left uterine horns also at random. This design also assumes that the effect of a treatment in a uterine horn is local with no systemic effects on the contralateral horn. The observed response in each female is denoted by the vector [x, y] (x, y = 0, 1,2,...) where x, y are the number of implantation sites in the left and right horns, respectively. This design was used for the estimation of dose-response lines and has been described elsewhere (Biggers & Schryver, 1964 The statistical analysis shows that the differences between the number of implantation sites in the control uterine horns and those receiving 78-8 and 788 ng antagonist are highly significant, and that the simultaneous administration of 312 pg ethanol has no effect. Therefore The concentration of Na2C03 in these solutions was 10 mM.
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In these experiments two controls were used. In one the uterine horn was left undisturbed, and in the other an injection of 2120 pg Na2C03 was made. The Na2C03 significantly reduced the number of implantation sites. The effects of the inhibitor were therefore compared with the effects of Na2C03 alone: intrauterine injection of 6160 ng inhibitor significantly reduced the number of implantation sites.
Meclofenamic acid
Four balanced incomplete block designs were needed to provide sufficient data because of the high incidence of bilateral zero responses. The results of the statistical analysis are summarized in Table 4 . The 22 bilateral zero responses were distributed amongst all treatments; there were no unilateral zero responses. Intrauterine injection of 5-92, 59-2 and 592 ng inhibitor significantly reduced the number of implantation sites.
Indomethacin
Two balanced incomplete block designs were needed to provide sufficient data. The two control treatments were intrauterine injection of saline only and the injection of 800 ng NaOH. The NaOH had no effect on the number of implantation sites, but the effects of the inhibitor were evaluated against the responses to 800 ng NaOH alone. There was a marginally significant increase of implantation sites after treatment with 72 ng indomethacin, but 720 and 7200 ng indomethacin had no effect. The results of another series of two balanced incomplete block designs to compare the effects of different doses of indomethacin made up in solutions containing NaHC03 instead of Na2C03 showed that indomethacin did not reduce the number The concentration of NaOH in these solutions was 3 mM.
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of implantation sites. Thus the combined results indicated that the intrauterine injection of indomethacin at the expected time of implantation did not reduce the number of implantation sites.
Discussion
The results show that the intrauterine injection of 18,18,20-trimethyl PGE-2, 7-oxa-13-prostynoic acid and meclofenamic acid shortly before implantation reduces the number of embryos that develop. The most active of the three compounds was meclofenamic acid and the least active 7-oxa-13-prostynoic acid. This ranking of activity is the reverse ofthat found in the inhibition of hatching of mouse blastocysts in vitro (Baskar et ai, 1981) . The relatively low activity or ineffectiveness of 7-oxa-13-prostynoic acid in vivo has been reported in other systems, e.g. gastrointestinal and antiinflammatory responses to PGE-1 and PGE-2 (Sanner & Eakins, 1976) , and the pulmonary vasoconstrictor response to PGF-2a (Nakano, Prancan & Moore, 1971) . Complete inhibition of implantation was not produced by 18,18,20-trimethyl PGE-2, 7-oxa-13-prostynoic acid and meclofenamic acid. This failure may be partly due to the difficulty of ensuring that the drugs were introduced into the uterus at the critical time(s) necessary for them to be maximally effective. This difficulty would become particularly critical for drugs with short half-lives. Also, clustering of the observed implantation sites away from the site of injection suggests that the antagonists did not reach all parts of the uterus.
It is possible that the local intrauterine injection of prostaglandin antagonists may lead to a systemic effect on the opposite horn. Such an effect, however, merely makes it more difficult to detect a dose-dependent response. The observed inhibitory effects of 18,18,20-trimethyl PGE-2, 7-oxa-13-prostynoic acid and meclofenamic acid are therefore considered real.
No reduction in the number of implantation sites followed the intrauterine injection of indomethacin when NaHC03 and NaOH solutions were used to solubilize the drug. Conner (Biggers et ai, 1978 (Mossman, 1971 Holmes & Gordashko (1980) have also shown that in the mouse prostaglandins, particularly PGE-2, are involved in the effects of oestrogens in the establishment of pregnancy.
(1) The inhibition of the hatching of mouse blastocysts in vitro by several prostaglandin antagonists suggests that prostaglandins are necessary for the accumulation of fluid in the blastocyst (Biggers et ai, 1978; Baskar et ai, 1981 (Psychoyos, 1961) . It was argued by Horan (1971) (Kennedy, 1977 (Kennedy, , 1979 Kennedy & Zamecnik, 1978) , hamster (Evans & Kennedy, 1978) and rabbit (Hoffman, DiPietro & McKenna, 1978) .
(3) Evidence has also accumulated during the past 5 years that prostaglandins may be required for decidualization itself. Tachi & Tachi (1974) found a limited decidual response after the intraperitoneal injection of large doses of PGF-2a in pseudopregnant rats. Sananes, Baulieu & LeGoascogne (1976) have shown that the intraluminal injection of PGF-2a into prepubertal rats maintained on progesterone results in massive decidualization. Moreover, the decidual reaction that follows a scratch of the endometrium was inhibited by indomethacin. Sananes et ai (1976) and Tobert (1976) suggested that endogenous prostaglandins mediate the decidual reaction. Hoffman, Strong, Davenport & Fròlich (1977) also elicited prominent decidual responses in rabbits by releasing PGE-2 and PGF-2afrom Silastic intrauterine implants: PGE-2 was the more potent agent. The release of histamine or oestradiol-17ß produced only small decidual responses in a few females. These observations provide strong evidence that prostaglandins are involved in decidualization. Hoffman et al. (1977) showed that the release of arachidonic acid also caused a decidual response, suggesting that the rabbit uterus possesses the enzyme components necessary for the arachidonic acid cascade.
Since prostaglandins play a role in several components of the process of implantation, prostaglandin antagonists are likely to be antifertility agents affecting several sites (Biggers, 1976) . Since these sites are spatially and temporarily separated, an antagonist may operate independently at each or some of the sites. If so the effectiveness of a dose will be given by /= -0-),
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